M&A Trinity Biotech sells life sciences supply business in $30m dealNasdaq-listed company said life sciences supply is no longer core to its long-term strategy
South Korean company takes 30% stake in Trinity Biotech for $45mNasdaq-listed Trinity develops products that are sold in more than 110 countries.